When is proximal gastrectomy indicated instead of total gastrectomy for gastric cancer?

Proximal Gastrectomy vs Total Gastrectomy for Gastric Cancer

Proximal gastrectomy is indicated for early gastric cancer (cT1cN0) located in the upper third of the stomach when adequate resection margins can be achieved, while total gastrectomy remains the standard for advanced disease (cT2-T4a or node-positive tumors). 1

Advanced Gastric Cancer (cT2-T4a or Node-Positive)

For clinically node-positive (cN+) or T2-T4a tumors, the standard surgical procedure is either total or distal gastrectomy—proximal gastrectomy is not recommended. 1, 2

Key Considerations for Advanced Disease:

• Total gastrectomy with D2 lymphadenectomy is the oncologic standard for advanced upper third gastric cancer to ensure adequate lymph node clearance and survival benefit 2

• Pancreatic invasion requiring pancreatectomy mandates total gastrectomy regardless of tumor location 1

• Tumors along the greater curvature with No. 4sb lymph node metastasis require total gastrectomy with splenectomy, even if the primary tumor could theoretically be removed by distal gastrectomy 1

Emerging Evidence for Selected Advanced Cases:

Recent research suggests proximal gastrectomy may be oncologically acceptable in highly selected advanced cases, but this remains investigational:

• For cT2-T4 lesions confined to the cardia and/or fornix, proximal gastrectomy without No. 12a dissection showed no distal lymph node metastasis in one study 3

• Gastric invasion length <40 mm was identified as a potential selection criterion for proximal gastrectomy in esophagogastric junction adenocarcinoma 4

• A 2026 propensity-matched study found comparable 3-year overall survival between proximal gastrectomy (81.8%) and total gastrectomy (70.8%) for upper third advanced gastric cancer, with better outcomes in tumors <50 mm 5

However, these findings are not yet incorporated into standard guidelines, and total gastrectomy remains the recommended approach for advanced disease. 1, 2

Early Gastric Cancer (cT1cN0)

Proximal gastrectomy is an acceptable option for cT1cN0 tumors located in the upper third of the stomach, provided adequate resection margins can be achieved. 1

Specific Indications:

• Tumor location must be in the proximal stomach (including the cardia/esophagogastric junction) 1

• At least half of the distal stomach should be preservable to justify function-preserving surgery 3, 6

• A 2 cm gross resection margin is required for T1 tumors 1

Lymph Node Dissection Requirements:

• D1+ lymphadenectomy is indicated for most cT1N0 tumors 1, 2

• D1 lymphadenectomy alone is acceptable for T1a tumors not meeting endoscopic resection criteria and for cT1bN0 differentiated-type tumors ≤1.5 cm 1, 2

Critical Resection Margin Requirements

Adequate resection margins are essential for oncologic outcomes and directly impact R0 resection rates:

• For T2 or deeper tumors with expansive growth (types 1 and 2): minimum 3 cm proximal margin 1, 2

• For infiltrative growth patterns (types 3 and 4): minimum 5 cm proximal margin 1, 2

• For T1 tumors: minimum 2 cm gross resection margin 1, 2

• Frozen section examination of the proximal resection margin is advisable when these margins cannot be achieved or for tumors invading the esophagus 1

Esophagogastric Junction Adenocarcinoma

For adenocarcinoma on the proximal side of the esophagogastric junction, both esophagectomy and proximal gastrectomy with gastric tube reconstruction should be considered. 1

• Gastric invasion length <40 mm may favor proximal gastrectomy over total gastrectomy in selected cases 4

Common Pitfalls and Caveats

Functional Considerations:

• Total gastrectomy results in post-gastrectomy syndrome in 5-50% of patients, including weight loss, dumping syndrome, and anemia 6

• Traditional proximal gastrectomy has high rates of reflux esophagitis (20-65%) and anastomotic stenosis, though newer anti-reflux reconstruction techniques (double flap, double-tract) may mitigate these complications 6

Oncologic Safety:

• Preoperative and intraoperative diagnosis of lymph node metastases remains unreliable, so D2 lymphadenectomy should be performed whenever nodal involvement is suspected 1

• At least 15 lymph nodes should be examined to ensure adequate staging 1, 2

• Routine splenectomy is not required unless the spleen or hilum is directly involved 1

Patient Selection Error:

The most critical error is performing proximal gastrectomy for advanced disease (T2-T4a or node-positive) outside of carefully controlled research settings, as this deviates from established oncologic standards and may compromise survival outcomes.